Obstetric and Gynecologic Imaging

What’s the Best Follow-Up Imaging for a Likely Benign Adnexal Mass in a Premenopausal Patient?

·
What's the Best Follow-Up Imaging for a Likely Benign Adnexal Mass in a Premenopausal Patient?

A 34-year-old female is in your clinic for a scheduled follow-up. Six weeks ago, an ultrasound for unrelated pelvic pain incidentally revealed a 4 cm simple-appearing adnexal cyst. The initial radiology report suggested short-interval follow-up to ensure stability or resolution, consistent with a benign functional cyst. The patient remains asymptomatic. Now, you must decide on the most appropriate, highest-value imaging study to re-evaluate this finding and confirm its benign nature. This article provides a detailed clinical workflow for this specific scenario, guiding you through the American College of Radiology (ACR) recommendations. For this presentation, the ACR rates `US duplex Doppler pelvis` as Usually Appropriate, establishing it as the standard of care.

Who Fits This Clinical Scenario for Adnexal Mass Follow-Up?

This guidance is specifically for the follow-up imaging of a premenopausal adult female with a previously identified adnexal mass that was characterized as likely benign on initial imaging.

Inclusion Criteria for This Workflow:

  • Patient: Adult, premenopausal female.
  • Clinical Status: No acute symptoms such as severe, sudden-onset pain, fever, or hemodynamic instability.
  • Imaging Context: This is a follow-up examination, not the initial diagnostic workup. An initial study (typically ultrasound) has already been performed.
  • Prior Findings: The mass was characterized as likely benign based on established criteria (e.g., a simple cyst, a classic hemorrhagic cyst, or a typical dermoid).

It is critical to distinguish this situation from other similar, but distinct, clinical scenarios that require a different approach. This workflow does not apply if:

  • The patient is postmenopausal: Follow-up criteria and the threshold for concern are different in postmenopausal women, routing to a separate ACR variant.
  • The initial ultrasound was indeterminate or suspicious for malignancy: If the initial study could not confidently classify the mass as benign, the next step is typically problem-solving imaging, not routine follow-up. This follows the ACR variant for indeterminate adnexal masses.
  • The patient presents with acute symptoms: Severe pain or fever suggests potential adnexal torsion, ruptured hemorrhagic cyst, or a tubo-ovarian abscess, which are acute conditions requiring a different, more urgent diagnostic pathway.

What Diagnoses Are You Working Up in This Scenario?

In this follow-up setting, the primary goal is not to establish a new diagnosis but to confirm the initial benign assessment by demonstrating resolution, expected evolution, or stability over time. The differential diagnosis remains centered on common, non-malignant entities.

Functional or Physiologic Cyst: This is the most common cause of a simple adnexal cyst in a premenopausal woman. These cysts (including follicular and corpus luteum cysts) are a normal part of the menstrual cycle. Follow-up imaging, typically performed after one or two cycles, is intended to show that the cyst has resolved or decreased in size, confirming its physiologic nature.

Hemorrhagic Cyst: This is a functional cyst that has bled internally. On ultrasound, it has a characteristic reticular or “fishnet” pattern. Follow-up imaging is crucial to document its expected evolution—the internal clot retracts and the cyst eventually resolves. Stability or resolution confirms the diagnosis and rules out a more complex neoplasm.

Endometrioma: Also known as a “chocolate cyst,” this is a manifestation of endometriosis. On ultrasound, it classically appears as a cyst with diffuse, low-level internal echoes (“ground-glass” appearance). Endometriomas do not resolve spontaneously. The purpose of follow-up is to confirm stability in size and appearance, as they are benign but persistent.

Mature Cystic Teratoma (Dermoid Cyst): This is a common benign germ cell tumor. It often has a characteristic appearance on ultrasound due to its mixed contents of fat, hair, and calcification (e.g., a Rokitansky nodule). Follow-up imaging serves to document its typical slow growth or stability over time.

Why Is Pelvic Ultrasound the Recommended Follow-Up for a Likely Benign Adnexal Mass?

The ACR designates four variations of pelvic ultrasound as Usually Appropriate for this scenario, with `US duplex Doppler pelvis` being a comprehensive choice. This recommendation is based on ultrasound’s high diagnostic accuracy for this specific task, its safety profile, and its accessibility.

The primary rationale is that ultrasound provides excellent spatial resolution and tissue characterization for the adnexa. It can reliably determine if a previously seen simple cyst has resolved, if a hemorrhagic cyst is evolving as expected, or if a known endometrioma or dermoid is stable. The addition of Duplex Doppler imaging allows for the assessment of blood flow. The absence of internal vascularity within a cyst is a strong indicator of a benign process, whereas the presence of solid components with internal flow would be a red flag prompting further investigation.

Why Alternative Studies Are Rated Lower:

  • MRI pelvis without and with IV contrast: Rated May be appropriate. While MRI offers superior soft tissue contrast and is an excellent problem-solving tool, it is not the first-line choice for routine follow-up of a likely benign finding. Its use should be reserved for cases where the follow-up ultrasound is inconclusive, reveals new worrisome features (like a growing solid component), or if the mass is too large or complex for ultrasound to fully evaluate. Using MRI for every routine follow-up would represent a significant increase in cost and a decrease in efficiency without adding diagnostic value in most cases.
  • CT pelvis with IV contrast: Rated Usually not appropriate. CT is poorly suited for characterizing the internal architecture of an adnexal mass compared to ultrasound or MRI. More importantly, it exposes the patient to ionizing radiation (ACR Relative Radiation Level ☢☢☢, 1-10 mSv), which is a critical consideration in a premenopausal patient who may require future imaging. Given the benign context, the risks of radiation exposure are not justified when a non-radiation alternative like ultrasound is superior.

In summary, pelvic ultrasound provides all the necessary information to manage this common clinical scenario safely and effectively, reserving more advanced imaging for indeterminate or suspicious cases.

What’s Next After Pelvic Ultrasound? Downstream Workflow

The results of the follow-up pelvic ultrasound will direct the next steps in management, which typically fall into one of three pathways.

  • If the Finding Has Resolved or Decreased: This is the expected outcome for a functional or hemorrhagic cyst. If the previously noted cyst is no longer visible or is significantly smaller, the benign nature is confirmed. No further imaging is necessary, and the patient can be reassured and returned to routine care.
  • If the Finding is Stable and Unchanged: This is the expected outcome for benign neoplasms like a small endometrioma or dermoid cyst. If the follow-up ultrasound shows the mass is unchanged in size and benign appearance, management often shifts to longer-term surveillance (e.g., annual ultrasound) or clinical follow-up, depending on the specific finding and its size. This confirms the indolent nature of the lesion.
  • If the Finding Has Changed Adversely or Appears Indeterminate: This is the least common but most important outcome to recognize. If the mass has grown significantly or developed new, complex features (e.g., a new solid nodule, thickened septations, or internal vascularity), it no longer fits the “likely benign” category. At this point, the patient’s clinical scenario shifts. The next appropriate step is to proceed to a problem-solving study, which is typically an MRI of the pelvis. This aligns with the ACR variant for an adnexal mass, indeterminate on initial pelvic US. A gynecologic oncology consultation should also be considered.

Pitfalls to Avoid (and When to Get Help)

Navigating the follow-up of a likely benign adnexal mass is generally straightforward, but several pitfalls can complicate management.

  • Inappropriate Imaging Interval: Ordering a follow-up too soon (e.g., within a week or two) may not allow enough time for a functional cyst to resolve, leading to unnecessary anxiety and further imaging. Conversely, waiting too long for a potentially complex mass can delay diagnosis. Follow-up is typically timed to occur after the next menstrual cycle.
  • Misclassifying the Initial Study: The entire follow-up pathway depends on the initial assessment being correct. If a subtly complex or malignant lesion was mischaracterized as “likely benign,” follow-up with ultrasound alone may be insufficient. Always review the initial report and images carefully.
  • Ignoring Patient Symptoms: If a patient develops new or worsening symptoms (pain, bloating, pressure) despite a “stable” imaging report, clinical re-evaluation is paramount. Symptoms should always take precedence over a reassuring imaging report.
  • Using CT for Follow-Up: Avoid the temptation to order a CT scan for follow-up. It provides less useful information for adnexal characterization than ultrasound and exposes the patient to unnecessary radiation.

If the follow-up ultrasound shows any new or concerning features, such as a growing solid component or increased vascularity, escalate care promptly with a referral to a gynecologist or gynecologic oncologist and order an MRI for further characterization.

Related ACR Topics and Tools

For a comprehensive overview of all clinical variants related to this topic, please consult the parent guide. For other scenarios or to explore the underlying data, the following GigHz tools are available.

Frequently Asked Questions

Why is follow-up imaging needed at all if the adnexal mass is considered ‘likely benign’?

Follow-up imaging serves to confirm the benign diagnosis. For functional cysts, which are very common in premenopausal women, demonstrating resolution over 1-2 menstrual cycles is the most definitive way to prove they are not neoplastic. For stable benign lesions like endometriomas or dermoids, follow-up establishes a baseline and confirms their indolent nature, preventing unnecessary surgical intervention.

What is the ideal timing for a follow-up ultrasound in this scenario?

The ideal timing is typically 6 to 12 weeks after the initial ultrasound. This interval allows for one to two full menstrual cycles to pass, giving a functional or hemorrhagic cyst adequate time to resolve. Performing the scan too early might show a persistent but resolving cyst, leading to continued uncertainty.

If the patient becomes pregnant, does that change the follow-up plan?

Yes, pregnancy significantly alters the management plan. A simple cyst or corpus luteum is a normal finding in early pregnancy. Follow-up of a simple-appearing adnexal mass is often deferred until the second trimester or after delivery, unless it is very large or symptomatic. MRI without contrast is the preferred problem-solving modality during pregnancy if there is a high level of concern.

Is a transvaginal ultrasound always necessary for this follow-up?

A transvaginal ultrasound is almost always the preferred method for evaluating the adnexa as it provides much higher resolution images than a transabdominal approach. A transabdominal scan is often performed first for a broader overview of the pelvis, but the detailed characterization of the mass relies on the transvaginal component. The ACR considers both approaches, alone or in combination, to be ‘Usually Appropriate’.

What if the follow-up ultrasound shows the cyst has grown but still appears to be a simple cyst?

A simple cyst that is growing requires careful evaluation. While it could still be a benign process, persistent growth raises the possibility of a benign cystic neoplasm (like a serous cystadenoma) rather than a transient functional cyst. Depending on the size and rate of growth, management might involve continued, closer surveillance or a referral to gynecology for consideration of MRI or surgical evaluation.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 26, 2026